The oligoadenylate-RNAseL pathway may provide a specific and low toxicity approach to therapy for breast cancer [ 2013 - 2015 ]

Research Grant

Researchers: Prof Christopher Ormandy (Principal investigator) ,  Dr David Gallego Ortega ,  Dr Samantha Oakes

Brief description We have discovered that a pathway used to fight viral infections can be triggered to produce massive cell death in the mammary gland. We hope to be able to trigger this response in breast cancers through the strategic combination of available drugs. If successful this project will establish a new therapeutic strategy for breast cancer.

Funding Amount $AUD 439,314.66

Funding Scheme Project Grants

Notes Standard Project Grant